- Home
- ACP vs MLAB Comparison
ACP vs MLAB Comparison
Compare ACP & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACP
- MLAB
- Stock Information
- Founded
- ACP 2010
- MLAB 1982
- Country
- ACP United States
- MLAB United States
- Employees
- ACP N/A
- MLAB N/A
- Industry
- ACP Investment Managers
- MLAB Industrial Machinery/Components
- Sector
- ACP Finance
- MLAB Industrials
- Exchange
- ACP Nasdaq
- MLAB Nasdaq
- Market Cap
- ACP 744.0M
- MLAB 680.0M
- IPO Year
- ACP N/A
- MLAB N/A
- Fundamental
- Price
- ACP $5.88
- MLAB $118.66
- Analyst Decision
- ACP
- MLAB Hold
- Analyst Count
- ACP 0
- MLAB 2
- Target Price
- ACP N/A
- MLAB $140.00
- AVG Volume (30 Days)
- ACP 337.9K
- MLAB 45.9K
- Earning Date
- ACP 01-01-0001
- MLAB 02-04-2025
- Dividend Yield
- ACP 17.79%
- MLAB 0.54%
- EPS Growth
- ACP N/A
- MLAB N/A
- EPS
- ACP N/A
- MLAB N/A
- Revenue
- ACP N/A
- MLAB $237,747,000.00
- Revenue This Year
- ACP N/A
- MLAB $13.48
- Revenue Next Year
- ACP N/A
- MLAB $4.74
- P/E Ratio
- ACP N/A
- MLAB N/A
- Revenue Growth
- ACP N/A
- MLAB 11.68
- 52 Week Low
- ACP $5.55
- MLAB $83.68
- 52 Week High
- ACP $7.17
- MLAB $155.12
- Technical
- Relative Strength Index (RSI)
- ACP 38.01
- MLAB 36.20
- Support Level
- ACP $5.85
- MLAB $121.89
- Resistance Level
- ACP $6.05
- MLAB $130.12
- Average True Range (ATR)
- ACP 0.06
- MLAB 4.42
- MACD
- ACP -0.01
- MLAB -0.38
- Stochastic Oscillator
- ACP 12.50
- MLAB 25.83
About ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.